Open AccessCost-Benefit Limitations of Extended, Outpatient Venous Thromboembolism Prophylaxis Following Surgery for Crohn’s Disease
Author(s) -
Ira L. Leeds,
Sandra R. DiBrito,
Joseph K. Canner,
Elliott R. Haut,
Bashar Safar
Publication year - 2019
Publication title -
diseases of the colon and rectum
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.575
H-Index - 162
eISSN - 1530-0358
pISSN - 0012-3706
DOI - 10.1097/dcr.0000000000001461
Subject(s) - medicine , quality adjusted life year , crohn's disease , quality of life (healthcare) , cost effectiveness , abdominal surgery , colorectal surgery , intensive care medicine , indirect costs , cost effectiveness analysis , decision analysis , life expectancy , disease , emergency medicine , surgery , population , mathematics , environmental health , business , risk analysis (engineering) , statistics , nursing , accounting
Patients with Crohn's disease are at increased risk of postoperative venous thromboembolism. Historically, extended outpatient prophylaxis has not met conventional measures of societal cost-benefit advantage. However, extended prophylaxis for patients with Crohn's disease may be more cost-effective because of the patients' high thrombotic risk and long life expectancy.